219
Views
8
CrossRef citations to date
0
Altmetric
Drug Evaluation

Valacyclovir for the treatment of Bell's palsy

, MD, , MD, , MD, , MD, , MD, , MD & , MD show all
Pages 2531-2536 | Published online: 08 Sep 2008

Bibliography

  • Yanagihara N. Incidence of Bell's palsy. Ann Otol Rhinol Laryngol Suppl 1988;137:3-4
  • Mccormick DP. Herpes-simplex virus as cause of Bell's palsy. Lancet 1972;1:937-9
  • Takasu T, Furuta Y, Sato KC, et al. Detection of latent herpes simplex virus DNA and RNA in human geniculate ganglia by the polymerase chain reaction. Acta Otolaryngol 1992;112:1004-11
  • Furuta Y, Fukuda S, Chida E, et al. Reactivation of herpes simplex virus type 1 in patients with Bell's palsy. J Med Virol 1998;54:162-6
  • Murakami S, Mizobuchi M, Nakashiro Y, et al. Bell's palsy and herpes simplex virus: identification of viral DNA in endoneural fluid and muscle. Ann Intern Med 1996;124:27-30
  • Sugita T, Murakami S, Yanagihara N, et al. Facial nerve paralysis induced by herpes simplex virus in mice, an animal model of acute and transient facial paralysis. Ann Otol Rhinol Laryngol 1995;104:574-81
  • Hato N, Hitsumoto Y, Honda N, et al. Immunologic aspects of facial nerve paralysis induced by herpes simplex virus infection in mice. Ann Otol Rhinol Laryngol 1998;107:633-7
  • Honda N, Hato N, Takahashi H, et al. Pathophysiology of facial nerve paralysis induced by herpes simplex virus type 1 infection. Ann Otol Rhinol Laryngol 2002;111:616-22
  • Takahashi H, Hitsumoto Y, Honda N, et al. Mouse model of Bell's palsy induced by reactivation of herpes simplex virus type 1. J Neuropathol Exp Neurol 2001;60:621-7
  • Adour KK. Otological complications of herpes zoster. Ann Neurol 1994;(Suppl 35):62-4
  • Furuta Y, Ohtani F, Sawa H, et al. Quantitation of varicella-zoster virus DNA in patients with Ramsay Hunt syndrome and zoster sine herpete. J Clin Microbiol 2001;39:2856-9
  • Murakami S, Hato N, Horiuchi J, et al. Treatment of Ramsay Hunt syndrome with acyclovir-prednisone: significance of early diagnosis and treatment. Ann Neurol 1997;41:353-7
  • Abiko Y, Keda M, Hondo R. Secretion and dynamics of herpes simplex virus in tears and saliva of patients with Bell's palsy. Otol Neurotol 2002;23:779-83
  • Murakami S, Honda N, Mizobuchi M, et al. Rapid diagnosis of varicella zoster virus infection in acute facial palsy. Neurology 1998;51:1202-5
  • Adour KK, Ruboyianes MJ, Von Doersten GP, et al. Bell's Palsy Treatment Acyclovir and Prednisone compared with Predonisone alone: a double-blind, randomised, controlled trial. Ann Otol Rhinol Laryngol 1996;105:371-8
  • De Diego JI, Prim MP, De Sarria MJ, et al. Idiopathic facial paralysis: a randomised, prospective and controlled study using single-dose prednisone versus acyclovir three times daily. Laryngoscope 1998;108:573-5
  • Hato N, Matsumoto S, Kisaki H, et al. Efficacy of early treatment of Bell's palsy with oral acyclovir and prednisolone. Otol Neurotol 2003;24:948-51
  • Sullivan FM, Swan IR, Donnan PT, et al. Early treatment with prednisolone or acyclovir in Bell's palsy. N Engl J Med 2007;357:1598-607
  • Soul Lawton J, Seaber E, On N. Absolute bioavailability and metabolic disposition of valacyclovir, the L-valyl ester of acyclovir, following oral administration to humans. Antimicrob Agents Chemother 1995;39;2759-64
  • Crumpacker CS. Significance of resistance of herpes simplex virus to acyclovir. J Am Acad Dermatol 1988;18:190-5
  • Maslen HL, Hughes D, Hursthouse M, et al. 6-azapyrimidine-2′-deoxy-4′-thionucleosides: antiviral agents against TK+ and TK- HSV and VZV strains. J Med Chem 2004;47:5482-91
  • Freeman S, Gardiner JM. Acyclic nucleosides as antiviral compounds. Mol Biotechnol 1996;5:125-37
  • PDR VALTREX Caplets; 2005
  • Jacobson MA. Valaciclovir (BW256U87): the L-valyl ester of acyclovir. J Med Virol 1993;(Suppl 1):150-3
  • Weller S, Blum MR, Doucette M, et al. Pharmacokinetics of the acyclovir pro-drug valacyclovir after escalating single- and multiple-dose administration to normal volunteers. Clin Pharmacol Ther 1993;54:595-605
  • Carlon R, Possamai C, Corbanese U. Acute renal failure and severe neurotoxicity following valacyclovir. Intensive Care Med 2005;31:1593
  • Wang LH, Schitz M, Weller S, et al. Pharmacokinetics and safety of multiple-dose valacyclovir in geriatric volunteers with and without concomitant diuretic therapy. Antimicrob Agents Chemother 1996;40:80-5
  • Rivaud E, Massiani MA, Vincent F, et al. Valacyclovir hydrochloride therapy and thrombotic thrombocytopenic purpura in an HIV-infected patient. Arch Intern Med 2000;160:1705-6
  • Brigden D, Whiteman P. The clinical pharmacology of acyclovir and its prodrugs. Scand J Infect Dis Suppl 1985;47:33-9
  • Wang LH, Schultz M, Weller S, et al. Pharmacokinetics and safety of multiple-dose valacyclovir in geriatric volunteers with and without concomitant diuretic therapy. Antimicrob Agents Chemother 1996;40:80-5
  • Peitersen E. Bell's palsy: the spontaneous course of 2,500 peripheral facial nerve palsies of different etiologies. Acta Otolaryngol Suppl 2002;549:4-30
  • Axelsson S, Lindberg S, Stjernquist Desatnik A. Outcome of treatment with valacyclovir and prednisone in patients with Bell's palsy. Ann Otol Rhinol Laryngol 2003;112:197-201
  • Antunes ML, Fukuda Y, Testa JRG. Clinical treatment of Bell's palsy: comparative study among valacyclovir plus deazacort, deflazacort and placebo. Acta AWHO 2000;19:68-75
  • Kawaguchi K, Inamura H, Abe Y, et al. Reactivation of herpes simplex virus type 1 and varicella-zoster virus and therapeutic effects of combination therapy with prednisolone and valacyclovir in patients with Bell's palsy. Laryngoscope 2007;117:147-56
  • Hato N, Yamada H, Kohno H, et al. Valacyclovir and prednisolone treatment for Bell's palsy: a multicenter, randomized, placebo-controlled study. Otol Neurotol 2007;28:408-13
  • Furuta Y, Ohtani F, Masuda Y, et al. Early diagnosis of zoster sine herpete and antiviral therapy for the treatment of facial palsy. Neurology 2000;55:708-10
  • Peterslund NA, Esmann V, Ipsen J, et al. Oral and intravenous acyclovir are equally effective in herpes zoster. J Amtimicrob Chemother 1984;14:185-9
  • Wassilew WS, Reimlinger S, Nasemann T, et al. Oral control for herpes zoster: a double-blind controlled trial in normal subjects. Br J Dermatol 1987;117:495-501
  • Hato N, Murakami S, Gyo K. Steroid and antiviral treatment for Bell's palsy. Lancet 2008;371(9627):1818-20

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.